Loteprednol Etabonate Suspension/ Drops
Product Images NDC 82260-361

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Loteprednol Etabonate (NDC 82260-361). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Americas Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Do Not Use (Image 01)

This text seems to be mentioning a warning or instruction related to a protective seal on a neckband. It advises not to use the item if the neckband is imprinted with "Protective Seal" and the yellow * is not intact. This may be a caution for ensuring the authenticity or safety of the product.*

FDA Label Image

Alrex Chemical Formula (Image 02)

Molecular weight of the compound is 466.96 g/mol.*

FDA Label Image

5ml Carton (Image 03)

This is a description of an ophthalmic suspension by Bausch & Lomb containing loteprednol etabonate 0.2%. The suspension is isotonic with an osmolality range, and it includes various inactive ingredients. The product is manufactured in the USA and should be stored upright at certain temperatures between 15°C and 25°C. It comes with a "Protactive Seal" to ensure integrity and requires vigorous shaking before use. Recommended usage instructions are provided for prescription information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.